Pregnancy is actually a acknowledged secondary cause of dyslipidemia, leading to a possible increase in triglyceride and LDL-C concentrations. Statin therapy is contraindicated during pregnancy resulting in confined options for dyslipidemia therapy in the course of pregnancy. Choice procedure soluti